Graphene Investments SAS Buys 44,600 Shares of UiPath, Inc. (NYSE:PATH)

Graphene Investments SAS increased its position in UiPath, Inc. (NYSE:PATH - Free Report) by 21.9% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 248,100 shares of the company's stock after buying an additional 44,600 shares during the period. Graphene Investments SAS's holdings in UiPath were worth $2,555,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Smartleaf Asset Management LLC boosted its holdings in UiPath by 88.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company's stock worth $31,000 after buying an additional 1,152 shares during the period. First Horizon Advisors Inc. boosted its holdings in shares of UiPath by 47.8% during the 4th quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company's stock valued at $32,000 after purchasing an additional 804 shares during the last quarter. Versant Capital Management Inc boosted its holdings in shares of UiPath by 198.6% during the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock valued at $31,000 after purchasing an additional 1,970 shares during the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of UiPath by 141.4% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company's stock valued at $38,000 after purchasing an additional 1,742 shares during the last quarter. Finally, CX Institutional bought a new position in shares of UiPath during the 1st quarter valued at about $36,000. Institutional investors own 62.50% of the company's stock.

UiPath Price Performance

Shares of NYSE PATH traded up $0.07 during mid-day trading on Monday, hitting $12.80. 8,490,316 shares of the company's stock traded hands, compared to its average volume of 10,408,799. The company's 50-day moving average is $12.44 and its two-hundred day moving average is $12.48. The company has a market capitalization of $6.85 billion, a P/E ratio of -106.66, a PEG ratio of 16.68 and a beta of 1.06. UiPath, Inc. has a 1 year low of $9.38 and a 1 year high of $15.93.

UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. The business had revenue of $356.62 million during the quarter, compared to the consensus estimate of $332.17 million. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.13 earnings per share. Equities analysts anticipate that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have commented on PATH. Barclays reissued an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Wells Fargo & Company reissued an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Evercore ISI increased their price objective on shares of UiPath from $11.00 to $15.00 and gave the company an "in-line" rating in a report on Friday, May 30th. Mizuho dropped their price objective on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Finally, Truist Financial increased their price objective on shares of UiPath from $12.00 to $13.00 and gave the company a "hold" rating in a report on Friday, May 30th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $13.83.

Insiders Place Their Bets

In other UiPath news, CFO Ashim Gupta sold 98,795 shares of the firm's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $12.01, for a total value of $1,186,527.95. Following the completion of the sale, the chief financial officer owned 987,322 shares of the company's stock, valued at $11,857,737.22. This trade represents a 9.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Daniel Dines sold 45,000 shares of the firm's stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $12.78, for a total transaction of $575,100.00. Following the completion of the sale, the chief executive officer directly owned 5,553,376 shares of the company's stock, valued at approximately $70,972,145.28. The trade was a 0.80% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 291,295 shares of company stock valued at $3,573,353 over the last 90 days. Insiders own 23.19% of the company's stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.